- 01Insulin made for a reason vs insulin made with no reason
C-peptide counts how much insulin the pancreas is releasing. When the glucose on the same draw is normal or high, the extra insulin is answering demand, most often insulin resistance or type 2 diabetes, and it is a slow problem worked up over weeks. When the glucose is low, the pancreas (or a drug or tumour) is releasing insulin the body did not need, and that pattern needs a doctor soon 3. The glucose drawn beside the C-peptide tells these two apart.
A high C-peptide means your pancreas is releasing a lot of insulin, and the commonest reason is insulin resistance, where the body needs extra insulin to keep blood sugar normal. C-peptide is the small fragment the pancreas cuts off each insulin molecule as it releases it, so one C-peptide goes out for every insulin 2 (the test itself is covered on our C-peptide page). Less often a medicine or a rare tumour is pushing insulin out, or the kidneys are clearing C-peptide slowly. The glucose on the same draw decides what a high result means; the eGFR (the kidney filtration score on most blood panels) checks whether the number can be trusted.
What counts as high
A C-peptide is high when it sits above the upper limit printed on your report. Mayo Clinic Laboratories gives a fasting reference interval of 1.1 to 4.4 ng/mL (0.36 to 1.46 nmol/L) 6; other labs print their own limits, so the range on your own report is the one to use (why ranges differ). Some consumer health sites call anything over 2.0 ng/mL high, but that sits well inside Mayo's fasting range, so a fasting result of 2 to 4 ng/mL is usually normal.
Where an example fasting C-peptide of 5.2 ng/mL sitsng/mL
Labs report C-peptide in three units. 1 ng/mL equals 0.331 nmol/L, or 331 pmol/L 2, so the same result can look very different on two reports.
| ng/mL | nmol/L | pmol/L |
|---|---|---|
| 2.0 | 0.66 | 662 |
| 3.0 | 0.99 | 993 |
| 4.4 (Mayo upper limit) | 1.46 | 1,456 |
| 6.0 | 1.99 | 1,986 |
No guideline grades a high C-peptide into mild, moderate or severe bands, so the table below uses only the range and the low-glucose threshold that changes what happens next, which comes from the Endocrine Society's guideline on low blood sugar 3.
| Band | US units | SI units | x upper limit | What it usually means | Usual next step |
|---|---|---|---|---|---|
| Within the range | 1.1 to 4.4 ng/mL | 0.36 to 1.46 nmol/L | Up to 1x | Normal fasting insulin output 6 | Nothing for the C-peptide itself |
| Above the range | Over 4.4 ng/mL | Over 1.46 nmol/L | Over 1x | Most often insulin resistance or type 2 diabetes; also a non-fasting sample or slow kidney clearance 12 | Read beside fasting glucose, A1c and eGFR; repeat fasting if the first sample was not |
| Not suppressed while glucose is low (act now) | 0.6 ng/mL or more while glucose is under 55 mg/dL | 0.2 nmol/L or more while glucose is under 3.0 mmol/L | Can be inside the range | The pancreas, a drug or a tumour is releasing insulin the body does not need 3 | Doctor the same day; workup by a specialist |
So a C-peptide of 1.5 ng/mL is inside every lab's range and still abnormal if the glucose drawn with it was 48 mg/dL 3. A low C-peptide has a separate set of causes, covered on low C-peptide.
When it is urgent
C-peptide has no widely used critical value; the urgency comes from the low blood sugar. See hypoglycemia and dizziness for how those spells feel.
Is it really high?
Before looking for a disease, rule out the reasons a single result reads high in a healthy person. They are listed from the most to the least common explanation of a one-off flag.
- Eating before the test pushes C-peptide up for several hours, so a non-fasting or random sample often sits above a fasting range; the fasting range does not apply to it 2. See fasting before a blood test.
- A unit mix-up makes a normal result look alarming: 1,200 pmol/L is about 3.6 ng/mL, which is inside Mayo's fasting range 26. See lab units explained.
- Lower kidney function raises C-peptide with no extra insulin being made, because the kidneys are its main route out 1. Check the eGFR on the same report, and a urine albumin-to-creatinine ratio if one was done.
- Sulfonylureas and meglitinides, prescription diabetes tablets that make the pancreas release insulin, raise C-peptide by design 3.
- Labs use different methods and ranges, which can move a borderline result across the line, so compare results from the same lab 2.
- A delay before the lab processes the sample rarely explains a high value; C-peptide drawn into an EDTA (lavender-top) tube stays stable at room temperature for about a day 2.
Why is my C-peptide high? Causes, most likely first
Three mechanisms raise C-peptide: more demand for insulin, a drug or tumour pushing insulin out, or slower clearance through the kidneys. Each cause below shows the clue that points to it and the test that confirms it. New to how insulin and blood sugar work? Start with blood sugar explained.
Common
| Cause | How it raises C-peptide | The clue | The test that confirms it |
|---|---|---|---|
| Insulin resistance, including with excess weight, PCOS or fatty liver | Muscle, fat and liver respond weakly to insulin, so the pancreas releases more to hold glucose steady | Normal fasting glucose and A1c; higher waist, triglycerides or blood pressure (the metabolic syndrome pattern; check yours with the waist-to-height ratio) | Fasting insulin, HOMA-IR (an insulin-resistance score), triglyceride/HDL ratio |
| Prediabetes or early type 2 diabetes | Resistance has outrun what the extra insulin can fix, so glucose starts to rise while output stays high | Fasting glucose or A1c in the prediabetes or diabetes range 5 | Fasting glucose, A1c, 2-hour glucose tolerance test (OGTT) |
| Non-fasting sample | A meal stimulates insulin and C-peptide release for hours 2 | Afternoon draw, or no fast recorded | A repeat fasting C-peptide with fasting glucose |
| Chronic kidney disease | The kidneys clear C-peptide; as filtration falls it builds up without extra insulin 1 | eGFR under 60, or a raised creatinine | eGFR, cystatin C, urine ACR |
CalculatoreGFR calculatorA high C-peptide means little until you know your kidney filtration; work out eGFR from creatinine, age and sex.Work it out Less common
| Cause | How it raises C-peptide | The clue | The test that confirms it |
|---|---|---|---|
| Sulfonylurea or meglitinide medicines (prescribed) | They make the pancreas's insulin-making cells release insulin whatever the blood sugar 3 | On the medication list; lows after a missed meal | Medication review; fasting glucose |
| Steroid medicines (prednisone and similar) and some antipsychotics | They cause insulin resistance, so the pancreas releases more insulin | On the medication list; glucose often rises too | Medication review; fasting glucose and A1c |
| Pregnancy, second and third trimester | Normal pregnancy hormones cause insulin resistance, so insulin output rises | Pregnant | Read with the pregnancy glucose screening your midwife or obstetrician arranges |
| Cushing's syndrome or acromegaly | Excess cortisol or growth hormone causes insulin resistance | Rapid weight gain, a rounder face, purple stretch marks, or enlarging hands and feet | Hormone tests a doctor orders |
| Low blood sugar after gastric bypass | After this surgery some people release too much insulin after meals, so insulin and C-peptide both run high during a low 3 | Lows after meals, usually months or years after surgery | Glucose, insulin and C-peptide drawn during a spell |
Must not miss
| Cause | How it raises C-peptide | The clue and red flag | The test that confirms it |
|---|---|---|---|
| Insulinoma, a tumour of insulin-making cells | The tumour releases insulin with no regard to glucose; it is rare, about 4 cases per million people a year, and most are benign 3 | Spells of confusion, sweating or odd behaviour when fasting, relieved by eating; same-day doctor, emergency for fainting or seizure | Supervised fast with glucose, insulin, C-peptide, proinsulin (the raw form insulin is made from) and a drug screen 3 |
| Hidden or accidental sulfonylurea intake | The drug drives insulin and C-peptide up exactly as an insulinoma does 3 | Low blood sugar in someone who is not prescribed it, sometimes from a pharmacy dispensing error; same-day doctor | Blood screen for sulfonylureas and meglitinides during a low 3 |
| Insulin autoimmune hypoglycemia (rare) | Antibodies bind the body's own insulin and release it at the wrong time, so insulin and C-peptide run high during a low | Lows, often after meals, in someone not on diabetes medicine; some cases follow certain drugs or supplements such as alpha-lipoic acid | Insulin antibodies, drawn as part of the low-blood-sugar workup 3 |
This part only applies if a glucose drawn with your C-peptide was low; if it was normal or high, skip to Symptoms. When low blood sugar is in the picture, blood results drawn during a low separate the sources. A doctor arranges this, often as a supervised fast of up to 72 hours in hospital or clinic 3.
| Source of the low | Insulin | C-peptide | Proinsulin | Drug screen |
|---|---|---|---|---|
| Injected insulin | High | Low (suppressed) | Low | Negative |
| Sulfonylurea or meglitinide | High | High | High | Positive |
| Insulinoma | High | High | High | Negative |
| Low blood sugar after gastric bypass | High | High | High | Negative |
| Insulin autoimmune hypoglycemia | Very high | High | High | Negative; insulin antibodies positive |
For your doctor: the Endocrine Society treats endogenous hyperinsulinism (too much of the body's own insulin) as shown when, with glucose under 55 mg/dL, insulin is at least 3 uU/mL, C-peptide at least 0.6 ng/mL (0.2 nmol/L) and proinsulin at least 5 pmol/L 3.
Symptoms
C-peptide itself causes no symptoms at any level. What people feel comes from the cause, and most people with a high C-peptide from insulin resistance feel nothing.
- Insulin resistance usually causes no symptoms; the skin and body signs that sometimes go with it are on the insulin resistance page.
- Once glucose climbs into the diabetes range, thirst and passing a lot of urine can appear; see always thirsty and frequent urination 5.
- Excess insulin from a drug or tumour causes low-sugar spells: shaking, sweating, hunger, confusion and, at worst, fainting or seizure, which ease after eating 3.
Tiredness and sugar cravings are common with or without a high C-peptide and point to no single cause; fatigue lists the tests that sort tiredness.
Is a high C-peptide harmful?
In a US national survey of adults without diabetes (NHANES III), those with higher fasting C-peptide had more deaths from heart disease and from all causes over the following years 7. That is an association, not proof that C-peptide itself does harm; the risk most likely comes from the insulin resistance behind it, which is why the cause is what gets treated.
Insulin resistance, prediabetes or type 2? Read it with your glucose
The tests that explain a high C-peptide
| Pattern on the same draw | What it suggests | Read next |
|---|---|---|
| High C-peptide, fasting glucose under 100 mg/dL and A1c under 5.7% | The pancreas is compensating for insulin resistance 5 | HOMA-IR |
| High C-peptide, glucose 100 to 125 mg/dL or A1c 5.7 to 6.4% | Prediabetes 5 | A1c vs fasting glucose |
| High C-peptide, glucose 126 mg/dL or more or A1c 6.5% or more | In the diabetes range; needs a confirming repeat test 5. If confirmed, fits type 2 with plenty of insulin still being made; type 1 is less likely, especially more than 3 years after diagnosis, a call for your diabetes team 1 | Type 1 vs type 2 diabetes |
| High C-peptide, low eGFR | Slow clearance; the number overstates insulin output 1 | Kidney function explained |
| High or normal C-peptide, glucose under 55 mg/dL | Excess insulin from the pancreas, a drug or a tumour; same-day doctor 3 | Hypoglycemia |
A worked example: a fasting C-peptide of 5.2 ng/mL with a fasting glucose of 94 mg/dL, an A1c of 5.5% and a normal eGFR fits the first row. The pancreas is working hard to keep glucose normal, which is an early sign of insulin resistance. If that is your pattern, ask your clinician whether to add a fasting insulin or HOMA-IR, and when to repeat the fasting glucose and A1c; A1c reflects about three months, so rechecking sooner tells you little.
CalculatorHOMA-IR calculatorIf you have a fasting insulin from the same morning, turn it and your glucose into one insulin-resistance score.Work it out For telling diabetes types apart in someone already diagnosed and treated with insulin, a review in Diabetic Medicine by Jones and Hattersley reads a random or stimulated C-peptide above about 600 pmol/L (1.8 ng/mL) as a type 2 pattern and under 200 pmol/L (0.6 ng/mL) as severe insulin deficiency typical of long-standing type 1, most useful more than 3 years after diagnosis 1. Diabetes itself is diagnosed from glucose and A1c 5.
How a doctor works it up
How a doctor usually works up a high C-peptide
When the cause is insulin resistance, repeat the test after about 3 months under the same conditions (fasting, morning, same lab), or sooner if lows appear, and look at the trend with glucose and A1c rather than any one value (why trends beat single readings).
How to lower a high C-peptide
A C-peptide comes down when its cause is treated. When the cause is insulin resistance, the best human evidence comes from the Diabetes Prevention Program, a US trial in 3,234 adults with raised glucose, which measured new diabetes rather than C-peptide itself 4. Resistance and aerobic exercise, enough sleep, and fewer refined carbs and sugary drinks all improve insulin sensitivity, and GLP-1 medicines are a prescription option a doctor may discuss. A high C-peptide from kidney disease or a prescribed medicine will not fall with diet.
| Change | Effect measured in humans | Evidence | Source |
|---|---|---|---|
| Lose about 7% of body weight and do 150 minutes a week of moderate activity | 58% fewer new cases of type 2 diabetes over about 3 years versus placebo | Randomised trial | Knowler 2002 4 |
| Metformin, only if a doctor prescribes it | 31% fewer new cases of type 2 diabetes versus placebo | Randomised trial | Knowler 2002 4 |
| Treat the kidney disease or change a prescribed drug (doctor-led) | Removes the reason for the high, without any change in insulin need | How the body works (no trial) | Jones and Hattersley 2013 1 |
Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk. The lifestyle intervention was more effective than metformin.Diabetes Prevention Program Research Group, N Engl J Med 2002 4
The two compounds below apply only when glucose is normal or high and there are no low-sugar spells; with lows, see a doctor first.
Compounds studied in people with high blood sugar
Early evidenceBerberineIn trials, mostly in people who already have type 2 diabetes, it lowered fasting glucose [[8]]; evidence in people with normal glucose is thin. It interacts with several prescription drugs and can add to the effect of diabetes medicines, and it is not advised in pregnancy, so ask your doctor or pharmacist first if you take any medicine.In our shop Chromium is often sold for blood sugar, and its evidence is weaker; our chromium page grades it, and berberine vs metformin compares the two above.
Free, no accountRead your blood testHave the full report? Read every marker on it free, with C-peptide beside glucose, A1c and eGFR.Read my results
Citations
- Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013;30(7):803-817.
- Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther 2017;8(3):475-487.
- Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009;94(3):709-728.
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403.
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S27-S49.
- Mayo Clinic Laboratories. C-Peptide, Serum (CPEP): reference values. Test catalog.
- Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc 2012;1(6):e003152.
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2012;2012:591654.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.






